CTXR vs PARA · rev $7.1M vs rev $5.0M
Citius Pharmaceuticals Inc (CTXR) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
PARA (PARA) common stock.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
CTXR currently screens at market cap $13.4M. PARA currently screens at market cap $0.
Not investment advice. Open the CTXR and PARA stock pages for the full models.
Not investment advice.